CTOR
Citius Oncology, Inc.
$0.84-0.03 (-3.45%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
CITIUS ONCOLOGY, INC. (CTOR) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 22 transactions (past 365 days)
| 2025-09-23 | 2025-09-19 | Holubiak Myron Z | Secretary | Award | 100,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Dutia Suren G | Director | Award | 300,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Holuka Eugene Myron | Director | Award | 300,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Holubiak Myron Z | Secretary | Award | 850,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Smith Robert Joseph | Director | Award | 300,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Webb Carol | Director | Award | 300,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Czuczman Myron | CMO | Award | 825,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Bartushak Jaime | CFO | Award | 825,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Mayersohn Joel David | Director | Award | 300,000 | $0.00 | $0 |
| 2025-09-23 | 2025-09-19 | Mazur Leonard L | CEO | Award | 1,700,000 | $0.00 | $0 |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.